XIAOMI-W
01810
BABA-W
09988
POP MART
09992
4
BYD COMPANY
01211
5
TENCENT
00700
HK Stock MarketDetailed Quotes
01652 FUSEN PHARM
- 0.290
- 0.0000.00%
Not Open May 7 16:08 CST
214.40MMarket Cap-1.05P/E (TTM)
0.290High0.280Low117.00KVolume0.280Open0.290Pre Close33.57KTurnover0.02%Turnover RatioLossP/E (Static)739.30MShares1.20052wk High0.54P/B214.40MFloat Cap0.23552wk Low--Dividend TTM739.30MShs Float19.975Historical High--Dividend LFY3.45%Amplitude0.235Historical Low0.286Avg Price1000Lot Size--Div YieldTTM--Div Yield LFY
FUSEN PHARM Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -546.72%-190.45M | ---- | 4.98%-29.45M | ---- | -230.27%-30.99M | ---- | -69.66%23.79M | ---- | 22.86%78.41M | ---- |
| Profit adjustment | ||||||||||
| Investment loss (gain) | -61.43%1.28M | ---- | 162.42%3.32M | ---- | -159.88%-5.31M | ---- | -174.03%-2.04M | ---- | --2.76M | ---- |
| Attributable subsidiary (profit) loss | 156.26%104.1M | ---- | 93.26%40.62M | ---- | 967.50%21.02M | ---- | 108.12%1.97M | ---- | -434.77%-24.25M | ---- |
| Impairment and provisions: | -46.71%9.08M | ---- | -48.82%17.04M | ---- | 72.70%33.3M | ---- | -30.14%19.28M | ---- | 3,688.82%27.6M | ---- |
| -Impairment of trade receivables (reversal) | -46.71%9.08M | ---- | 461.83%17.04M | ---- | ---4.71M | ---- | ---- | ---- | 745.12%4.96M | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --22.64M | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | 97.13%38.01M | ---- | --19.28M | ---- | ---- | ---- |
| Revaluation surplus: | 8.33%338K | ---- | 2,500.00%312K | ---- | -100.75%-13K | ---- | 158.77%1.74M | ---- | ---2.97M | ---- |
| -Other fair value changes | 8.33%338K | ---- | 2,500.00%312K | ---- | -100.75%-13K | ---- | 158.77%1.74M | ---- | ---2.97M | ---- |
| Asset sale loss (gain): | -100.27%-3K | ---- | -32.57%1.12M | ---- | -86.15%1.67M | ---- | 6,550.28%12.04M | ---- | 1,545.45%181K | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -100.27%-3K | ---- | -32.57%1.12M | ---- | -86.15%1.67M | ---- | 6,550.28%12.04M | ---- | --181K | ---- |
| Depreciation and amortization: | 16.52%41.71M | ---- | 4.79%35.8M | ---- | 43.62%34.16M | ---- | 5.91%23.79M | ---- | 5.77%22.46M | ---- |
| -Depreciation | 16.52%41.71M | ---- | 4.79%35.8M | ---- | 43.62%34.16M | ---- | 5.91%23.79M | ---- | 5.77%22.46M | ---- |
| Financial expense | 113.03%18.84M | ---- | -43.76%8.84M | ---- | 121.57%15.73M | ---- | 26.01%7.1M | ---- | 1.88%5.63M | ---- |
| Special items | -327.42%-821K | ---- | 145.07%361K | ---- | -952.13%-801K | ---- | -99.45%94K | ---- | 356.10%17.02M | ---- |
| Operating profit before the change of operating capital | -120.43%-15.93M | ---- | 13.41%77.97M | ---- | -21.65%68.75M | ---- | -30.81%87.75M | ---- | 42.49%126.83M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 148.24%24.64M | ---- | -556.14%-51.07M | ---- | 168.14%11.2M | ---- | 3.42%-16.43M | ---- | -132.47%-17.01M | ---- |
| Accounts receivable (increase)decrease | 45.25%72.42M | ---- | 155.06%49.86M | ---- | -448.69%-90.56M | ---- | 310.92%25.97M | ---- | 74.68%-12.31M | ---- |
| Accounts payable increase (decrease) | 1,306.79%26.5M | ---- | -103.10%-2.2M | ---- | 388.78%70.83M | ---- | -138.25%-24.53M | ---- | 177.62%64.13M | ---- |
| prepayments (increase)decrease | 130.83%12.38M | ---- | -1,903.55%-40.15M | ---- | 123.18%2.23M | ---- | -274.42%-9.6M | ---- | -115.18%-2.57M | ---- |
| Special items for working capital changes | 133.48%14.56M | ---- | -197.28%-43.5M | ---- | 844.87%44.72M | ---- | -150.00%-6M | ---- | -16.08%12.01M | ---- |
| Cash from business operations | 1,581.31%134.58M | 85.79%-5.35M | -108.48%-9.09M | 18.60%-37.67M | 87.47%107.16M | -200.76%-46.27M | -66.59%57.16M | -59.66%45.92M | 313.74%171.08M | 1,015.70%113.82M |
| China income tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 48.15%-8.05M |
| Other taxs | 92.36%-847K | 89.50%-912K | -432.76%-11.09M | -11,477.33%-8.68M | 135.48%3.33M | 99.26%-75K | 47.42%-9.4M | ---10.12M | ---17.87M | ---- |
| Net cash from operations | 762.82%133.73M | 86.49%-6.26M | -118.26%-20.18M | -0.01%-46.35M | 131.32%110.49M | -229.45%-46.35M | -68.82%47.77M | -66.15%35.8M | 651.38%153.21M | 478.36%105.77M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -92.11%24K | ---- | -26.39%304K | ---- | -35.97%413K | ---- | -77.67%645K | ---- | 46.95%2.89M | ---- |
| Loan receivable (increase) decrease | -90.77%-86.15M | -56.25%3.5M | -395.15%-45.16M | -13.98%8M | 143.71%15.3M | 120.67%9.3M | ---35M | ---45M | ---- | ---- |
| Sale of fixed assets | ---- | ---- | 5,533.33%169K | ---- | -99.82%3K | ---- | 1,884.15%1.63M | ---- | 173.33%82K | ---- |
| Purchase of fixed assets | 7.97%-60.96M | -9.41%-45.99M | -177.60%-66.24M | -115.81%-42.04M | 78.33%-23.86M | 71.35%-19.48M | -87.80%-110.13M | -46.32%-67.99M | -1.43%-58.65M | -1,207.03%-46.47M |
| Purchase of intangible assets | 31.12%-15.34M | ---854K | -290.70%-22.27M | ---- | ---5.7M | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---153M | ---153M | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | -94.72%715K | ---- | -78.82%13.54M | -53.61%10.26M | --63.93M | --22.12M |
| Cash on investment | 96.46%-1M | 97.55%-1M | ---28.28M | -2,304.71%-40.88M | ---- | ---1.7M | 99.14%-654K | ---- | ---76.46M | ---19.25M |
| Other items in the investment business | ---- | ---- | ---- | 525.00%500K | ---- | -94.08%80K | ---- | -97.31%1.35M | ---- | 206.00%50.34M |
| Net cash from investment operations | -1.21%-163.42M | 40.41%-44.35M | -1,129.73%-161.48M | -530.71%-74.42M | 95.36%-13.13M | 95.36%-11.8M | -314.94%-282.98M | -3,870.74%-254.37M | 73.90%-68.2M | 103.59%6.75M |
| Net cash before financing | 83.65%-29.69M | 58.09%-50.61M | -286.58%-181.65M | -107.70%-120.77M | 141.39%97.36M | 73.40%-58.14M | -376.69%-235.21M | -294.26%-218.57M | 135.29%85.01M | 152.17%112.52M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 127.61%776.09M | 119.40%426.14M | 19.58%340.98M | -26.34%194.23M | -1.79%285.14M | 68.08%263.68M | 37.68%290.33M | -25.04%156.88M | 75.73%210.87M | 161.61%209.29M |
| Refund | -231.95%-734.43M | -200.48%-382.36M | 27.82%-221.25M | 33.40%-127.25M | -24.82%-306.53M | -10.08%-191.07M | -11.62%-245.57M | 8.65%-173.57M | -120.00%-220M | -90.00%-190M |
| Interest paid - financing | 55.12%-57K | 23.38%-59K | 24.85%-127K | 24.51%-77K | -212.96%-169K | -104.00%-102K | ---54K | ---50K | ---- | ---- |
| Dividends paid - financing | ---- | ---- | ---- | ---- | 16.22%-6.96M | ---7.04M | -164.10%-8.31M | ---- | 41.27%-3.15M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 96.48%-1.99M | ---- | ---56.32M |
| Other items of the financing business | 14.30%-24.38M | -388.06%-15.06M | -28.57%-28.44M | 114.53%5.23M | -42.47%-22.12M | -627.57%-35.99M | 85.08%-15.53M | -0.55%-4.95M | -1,031.19%-104.06M | -22.51%-4.92M |
| Net cash from financing operations | -81.93%15.99M | -73.59%18.7M | 270.97%88.5M | 148.14%70.81M | -352.18%-51.77M | 219.27%28.54M | 117.65%20.53M | 42.97%-23.93M | -2,236.06%-116.33M | -65.85%-41.95M |
| Effect of rate | 12.96%-94K | -180.00%-120K | -107.45%-108K | -87.20%150K | 212.32%1.45M | 258.81%1.17M | 51.94%-1.29M | -172.57%-738K | -150.19%-2.69M | 62.72%1.02M |
| Net Cash | 85.29%-13.7M | 36.13%-31.91M | -304.31%-93.15M | -68.73%-49.96M | 121.24%45.59M | 87.79%-29.61M | -585.45%-214.68M | -443.64%-242.5M | 86.70%-31.32M | 129.28%70.57M |
| Begining period cash | -72.80%34.85M | -72.80%34.85M | 58.03%128.11M | 58.03%128.11M | -72.71%81.06M | -72.71%81.06M | -10.27%297.04M | -10.27%297.04M | -41.00%331.04M | -41.00%331.04M |
| Cash at the end | -39.58%21.06M | -96.39%2.82M | -72.80%34.85M | 48.78%78.3M | 58.03%128.11M | -2.18%52.63M | -72.71%81.06M | -86.64%53.8M | -10.27%297.04M | 25.52%402.63M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.